Johnson & Johnson
Latest statistics and disclosures from Johnson & Johnson's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PTGX, NBTX, MGTX, RAPP, CVRX, and represent 89.40% of Johnson & Johnson's stock portfolio.
- Added to shares of these 1 stock: RLYB.
- Started 1 new stock position in RLYB.
- Reduced shares in these 3 stocks: Rallybio Corp, LYEL, NNOX.
- Sold out of its positions in LYEL, Rallybio Corp.
- Johnson & Johnson was a net seller of stock by $-3.0M.
- Johnson & Johnson has $652M in assets under management (AUM), dropping by 17.53%.
- Central Index Key (CIK): 0000200406
Tip: Access up to 7 years of quarterly data
Positions held by Johnson & Johnson consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Johnson & Johnson
Johnson & Johnson holds 16 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Protagonist Therapeutics (PTGX) | 39.6 | $258M | 2.4M | 105.40 |
|
|
| Nanobiotix Sponsored Ads (NBTX) | 26.6 | $174M | 5.6M | 30.87 |
|
|
| Meiragtx Holdings (MGTX) | 8.8 | $58M | 6.6M | 8.66 |
|
|
| Rapport Therapeutics (RAPP) | 8.6 | $56M | 1.8M | 31.29 |
|
|
| CVRX (CVRX) | 5.8 | $38M | 4.0M | 9.46 |
|
|
| Contineum Therapeutics Cl A (CTNM) | 4.0 | $26M | 2.0M | 13.06 |
|
|
| Legend Biotech Corporation Sponsored Ads (LEGN) | 2.3 | $15M | 815k | 18.09 |
|
|
| Xencor (XNCR) | 1.4 | $9.0M | 748k | 12.06 |
|
|
| Procept Biorobotics Corp (PRCT) | 1.4 | $9.0M | 358k | 25.01 |
|
|
| Fate Therapeutics (FATE) | 0.6 | $4.1M | 3.4M | 1.20 |
|
|
| Neumora Therapeutics (NMRA) | 0.6 | $3.6M | 1.8M | 1.95 |
|
|
| Rallybio Corp (RLYB) | 0.2 | $1.4M | NEW | 153k | 8.97 |
|
| Vor Biopharma Com New (VOR) | 0.1 | $959k | 54k | 17.84 |
|
|
| D Fluidigm Corp Del (LAB) | 0.0 | $287k | 312k | 0.92 |
|
|
| Nano-X Imaging Ord Shs (NNOX) | 0.0 | $190k | -47% | 84k | 2.27 |
|
| Adicet Bio Com New (ACET) | 0.0 | $155k | 23k | 6.81 |
|
Past Filings by Johnson & Johnson
SEC 13F filings are viewable for Johnson & Johnson going back to 2021
- Johnson & Johnson 2026 Q1 filed May 13, 2026
- Johnson & Johnson 2025 Q3 restated filed March 18, 2026
- Johnson & Johnson 2025 Q4 restated filed March 18, 2026
- Johnson & Johnson 2025 Q4 filed Feb. 13, 2026
- Johnson & Johnson 2025 Q3 filed Nov. 13, 2025
- Johnson & Johnson 2025 Q2 filed July 22, 2025
- Johnson & Johnson 2025 Q1 filed May 7, 2025
- Johnson & Johnson 2024 Q4 filed Feb. 13, 2025
- Johnson & Johnson 2024 Q3 filed Nov. 13, 2024
- Johnson & Johnson 2024 Q2 filed Aug. 9, 2024
- Johnson & Johnson 2024 Q1 filed May 10, 2024
- Johnson & Johnson 2023 Q3 filed Nov. 9, 2023
- Johnson & Johnson 2023 Q2 filed Aug. 2, 2023
- Johnson & Johnson 2023 Q1 filed May 11, 2023
- Johnson & Johnson 2022 Q4 filed Feb. 9, 2023
- Johnson & Johnson 2022 Q3 filed Nov. 10, 2022